FemtoDx is a cutting-edge healthcare company that aims to revolutionize the way we monitor and diagnose cardiovascular diseases. With a focus on home-based monitoring, they offer a panel of clinically validated biomarkers for detecting heart failure and stroke before they happen. Unlike existing point-of-care tests, FemtoDx's solutions are not only more sensitive and accurate but also portable and connected, making them convenient for both clinicians and patients.

With 14 million heart failure and stroke patients in the US alone, the need for regular monitoring at the molecular level is crucial. FemtoDx addresses this challenge by providing ultrasensitive and ultra-specific tests performed with medical devices that are wearable or disposable, coupled with mobile connectivity. Led by an experienced team of experts, including CEO and Founder Dr.

Raj Mohanty, FemtoDx is at the forefront of bringing healthcare to where it truly belongs: your body